BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 33079404)

  • 21. Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?
    Shah R; Xia C; Krailo M; Amatruda JF; Arul SG; Billmire DF; Brady WE; Covens A; Gershenson DM; Hale JP; Hurteau J; Murray MJ; Nicholson JC; Olson TA; Pashankar F; Rodriguez-Galindo C; Shaikh F; Stark D; Frazier AL; Stoneham S
    Gynecol Oncol; 2018 Aug; 150(2):253-260. PubMed ID: 29884437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors in children with extracranial germ cell tumors treated with cisplatin-based chemotherapy.
    Kim J; Lee NH; Lee SH; Yoo KH; Sung KW; Koo HH; Seo JM; Lee SK
    Korean J Pediatr; 2015 Oct; 58(10):386-91. PubMed ID: 26576183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of tumor site and histology on long-term survival in 193 children with extracranial germ cell tumors.
    De Backer A; Madern GC; Pieters R; Haentjens P; Hakvoort-Cammel FG; Oosterhuis JW; Hazebroek FW
    Eur J Pediatr Surg; 2008 Feb; 18(1):1-6. PubMed ID: 18302061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysis.
    Hartmann JT; Einhorn L; Nichols CR; Droz JP; Horwich A; Gerl A; Fossa SD; Beyer J; Pont J; Schmoll HJ; Kanz L; Bokemeyer C
    J Clin Oncol; 2001 Mar; 19(6):1641-8. PubMed ID: 11250992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary mediastinal and retroperitoneal malignant germ cell tumors in children and adolescents: Results of the TGM95 trial, a study of the French Society of Pediatric Oncology (Société Française des Cancers de l'Enfant).
    Sudour-Bonnange H; Faure-Conter C; Martelli H; Hameury F; Fresneau B; Orbach D; Vérité C
    Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28306215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Suggested Prognostic Reclassification of Intermediate and Poor-Risk Nonseminomatous Germ Cell Tumors.
    Necchi A; Pond GR; Nicolai N; Giannatempo P; Raggi D; Adra N; Hanna NH; Salvioni R; Einhorn LH; Albany C
    Clin Genitourin Cancer; 2017 Apr; 15(2):306-312.e3. PubMed ID: 27594554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Germ Cell Tumors in Adolescents and Young Adults.
    Fonseca A; Frazier AL; Shaikh F
    J Oncol Pract; 2019 Aug; 15(8):433-441. PubMed ID: 31404512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of
    Timmerman DM; Eleveld TF; Gillis AJM; Friedrichs CC; Hillenius S; Remmers TL; Sriram S; Looijenga LHJ
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study.
    Bajorin DF; Sarosdy MF; Pfister DG; Mazumdar M; Motzer RJ; Scher HI; Geller NL; Fair WR; Herr H; Sogani P
    J Clin Oncol; 1993 Apr; 11(4):598-606. PubMed ID: 8386751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first-line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3).
    Tran B; Ruiz-Morales JM; Gonzalez-Billalabeitia E; Patrikidou A; Amir E; Seidel C; Bokemeyer C; Fankhauser C; Hermanns T; Rumyantsev A; Tryakin A; Brito M; Fléchon A; Kwan EM; Cheng T; Castellano D; Garcia Del Muro X; Hamid AA; Ottaviano M; Palmieri G; Kitson R; Reid A; Heng DYC; Bedard PL
    Cancer Med; 2020 Jan; 9(1):116-124. PubMed ID: 31715650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methotrexate, paclitaxel, ifosfamide, and cisplatin in poor-risk nonseminomatous germ cell tumors.
    Pectasides D; Pectasides E; Papaxoinis G; Xiros N; Kamposioras K; Tountas N; Economopoulos T
    Urol Oncol; 2010; 28(6):617-23. PubMed ID: 19110454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
    Cushing B; Giller R; Cullen JW; Marina NM; Lauer SJ; Olson TA; Rogers PC; Colombani P; Rescorla F; Billmire DF; Vinocur CD; Hawkins EP; Davis MM; Perlman EJ; London WB; Castleberry RP; ;
    J Clin Oncol; 2004 Jul; 22(13):2691-700. PubMed ID: 15226336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of post-chemotherapy radiation in the management of children and adolescents with primary advanced malignant mediastinal germ cell tumors.
    Huang J; Tan Y; Zhen Z; Lu S; Sun F; Zhu J; Wang J; Liao R; Sun X
    PLoS One; 2017; 12(8):e0183219. PubMed ID: 28813488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trial.
    Subbiah V; Meric-Bernstam F; Mills GB; Shaw KR; Bailey AM; Rao P; Ward JF; Pagliaro LC
    J Hematol Oncol; 2014 Aug; 7():52. PubMed ID: 25085632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcomes of pediatric and adolescent mediastinal germ cell tumors: a single pediatric oncology institutional experience.
    Grabski DF; Pappo AS; Krasin MJ; Davidoff AM; Rao BN; Fernandez-Pineda I
    Pediatr Surg Int; 2017 Feb; 33(2):235-244. PubMed ID: 27838767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of refractory germ-cell tumours with single-agent cabazitaxel: a German Testicular Cancer Study Group case series.
    Oing C; Hentrich M; Lorch A; Gläser D; Rumpold H; Ochsenreither S; Richter S; Dieing A; Zschäbitz S; Pereira RR; Bokemeyer C; Seidel C
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):449-455. PubMed ID: 31838576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical utility of plasma miR-371a-3p in germ cell tumors.
    Mego M; van Agthoven T; Gronesova P; Chovanec M; Miskovska V; Mardiak J; Looijenga LHJ
    J Cell Mol Med; 2019 Feb; 23(2):1128-1136. PubMed ID: 30536846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salvage high-dose chemotherapy for children with extragonadal germ-cell tumours.
    De Giorgi U; Rosti G; Slavin S; Yaniv I; Harousseau JL; Ladenstein R; Demirer T; Dini G;
    Br J Cancer; 2005 Aug; 93(4):412-7. PubMed ID: 16106248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of primary malignant germ cell tumor of the mediastinum.
    Sakurai H; Asamura H; Suzuki K; Watanabe S; Tsuchiya R
    Jpn J Clin Oncol; 2004 Jul; 34(7):386-92. PubMed ID: 15342665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One-stage approach for retroperitoneal and mediastinal metastatic testicular tumor resection.
    Fadel E; Court B; Chapelier AR; Droz JP; Dartevelle P
    Ann Thorac Surg; 2000 Jun; 69(6):1717-21. PubMed ID: 10892913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.